news-med.jpg

Evotec achieves second milestone in diabetes alliance with Sanofi

Companies are at the forefront of beta cell replacement therapeutic research for diabetes Evotec receives € 3 Million payment from Sanofi Milestone further demonstrates advancement of EVT Innovate initiative “TARGETBCD”

Topics: Corporate, Sanofi, Evotec, beta cell replacement, TARGETBCD, diabetes Read More